Results 231 to 240 of about 2,088,860 (358)

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

open access: yesMolecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková   +14 more
wiley   +1 more source

Relationship Factors in Treating Substance Use Disorders [PDF]

open access: yes, 2005
Kelly, John   +3 more
core   +1 more source

Correction: Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia’s drug supply

open access: yesHarm Reduction Journal
Bruce Wallace   +12 more
doaj   +1 more source

The Use and Physical Effects of Intravaginal Substances in Zairian Women

open access: bronze, 1993
Richard C. D. Brown   +2 more
openalex   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

open access: yesMolecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim   +11 more
wiley   +1 more source

Prevalence of Impairing Substance Use in Injured Drivers.

open access: yesJAMA Netw Open
Brubacher JR   +21 more
europepmc   +1 more source

A Survey of Adolescent and Caregiver Perceptions of Substance Use Screening in Pediatric Emergency Departments. [PDF]

open access: yesJ Am Coll Emerg Physicians Open
Sandelich S   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy